Latest filing published 02 Jun 2015 for QUIDEL CORP.
Insider track record
No signal scores available.
Mark W. Smits: trading record in brief
Filings by Mark W. Smits span 2 companies, the busiest being Quidel Corp and Neogenomics Inc. The record holds 9 filings, for trades running from 18 May 2011 to 1 June 2015.
No open-market purchase appears, only 1 sale worth €43k. Outside the open market, there are 7 share grants and 1 option exercise.
Most recently, on 2 June 2015, the filings show a share grant in Quidel Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark W. Smits
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,136 shares0Common StockSEC:0001209191-15-049158:0
- 2,497 shares@ US$21.97Common StockSEC:0001209191-15-049158:1
- 1,635 shares0Common StockSEC:0001209191-15-022589:0
- 439 shares@ US$26.41Common StockSEC:0001209191-15-022589:1
- 788 shares@ US$0.01Common StockSEC:0001209191-15-019927:0
- 208 shares@ US$25.68Common StockSEC:0001209191-15-019927:1
- 9,136 shares@ US$0.01Restricted StockSEC:0001209191-11-033022:0
- 45,000 shares@ US$1.02Common StockSEC:0001144204-11-031358:0
- 45,000 shares@ US$1.37Common StockSEC:0001144204-11-031358:1
9 of 9 declarations
